PROSTATA BEZI XAVFSIZ GIPERPLAZIYASIDA JARROHLIK AMALIYOTLARINI SAMARADORLIGINI ANIQLASH
Abstract
Prostata bezi xavfsiz giperplaziyasi (PBXG) — katta yoshdagi erkaklar orasida ko’p uchraydigan kasalliklardan biri. Kasallikni rivojlanishi bemorlar yoshi bilan parallel ravishda ayniqsa 40 yoshdan keyin prostata bezi xajmining kattalashishi tezlashadi. Barcha o’tkazilgan gistologik tekshiruvlar natijasida 50 yoshdan yuqori bo’lgan 80% erkaklarda prostata bezi gipreplaziyasi tasdiqlangan. PBXG aniqlangan bemorlarni taxminan 50% qismini operativ davoga muxtoj ekanligini tibbiy statiktik ma’lumotlar tasdiqlaydi.
References
Шадманов М.А., Садикова Д.И. Профилактика воспаления после операции доброкачественной гиперплазии предстательной железы// Журнал «Экономика и социум», Москва, 2023, 5(108), с.91-94
Buzelin J.M., Delauche-Cavallier M.C. et al. Clinical uroselectivity: evidence from patients treated with slow release alfusozin for symptomatic benighn prostatic obstruction// Br J Urol. 2017; 79: 898-906.
Djavan В. Мeta-analysis on the efficacy and tolerability of a 1- adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of the benign prostatic obstruction// Eur. Urol. - 2019. - Vol. 36. - P. 11-13.
Etreby M.F., Habenicht U.F. The function and the role of aromatase inhibitors in the treatment of BPH// In Benign prostatic hyperplasia. – Wiley Liss, 2020. -P.209-230.
Mahler C.Y., Peeling W.B. The normal prostate. In Altwein (edt) with benign prostatic hyperplasia a diagnosis and treatment primer// Merk and Co.Inc. - 2022. - P. 210-213.
